Posted in    Nov 7th, 2014

Stemina Published in PLOS One

Stemina Biomarker Discovery, Inc. today announced the publication of research conducted in collaboration with the MIND Institute at the University of California-Davis to identify biomarkers in the blood of children with autism spectrum disorders (ASD) that can distinguish them from typically developing children. The research is the first of its kind and has the potential to enable earlier diagnosis and treatment of children with ASD from a blood sample. 

Visit Website